This study is looking at whether a wearable device called BioIntelliSense can help predict if patients who have been hospitalized for sepsis (a serious infection that can lead to organ damage) will need to be readmitted to the hospital within 30 days of going home. We want to see if the information from the biopatch, which monitors things like heart rate and breathing, can improve our ability to predict these readmissions. You may be able to join if you are 18 or older, were diagnosed with sepsis in the emergency department or hospital, and were admitted to the hospital. The study aims to find out if using the biopatch provides useful data to better predict when someone might need to return to the hospital after sepsis.

Study design

This is an observational study involving 200 participants. It is a longitudinal cohort study, meaning participants are followed over time.

What's involved

Participants will wear a BioIntelliSense biopatch on their chest for 30 days after leaving the hospital, or until they are readmitted.

Compensation

Not stated in the trial record.

Follow-up

Participants are followed for 30 days after hospital discharge to check for readmission.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.